Avin Darou is a private, commercial pharmaceutical company established in April 2008 by an experienced team. Benefiting from the team’s previous experience and knowledge of the pharmaceutical business and market, the company experienced rapid growth and achieved an excellent start by cooperating with major international companies such as CSL Behring, Serum Institute of India, BD, Novartis Vaccines, Mylan, and Crucell. Initially, the company focused on the market of vaccine and plasma-derived products and, after becoming the largest importer in these segments, it began to strengthen its business by acquiring several pharmaceutical manufacturing and distribution companies.
Currently, Avin Darou is the largest importer of vaccine and plasma-derived products in Iran and the agent of BD, CSL Behring, CSL Seqirus, and Serum Institute of India. With a successful history in the pharmaceutical market of Iran, Avin Darou is ready to invest in new pharmaceutical businesses and expand its portfolio.
Avin Darou is one of the subsidiaries of the Avin Darou Pharmaceutical Group, which cooperates with various companies such as Momtaz Distribution Company, Darou Darman Pars (DDP), Donya Darou Sepeher (DDS), Nano Daru, and Gostaresh Bazargani Darou Darman Pars (GDDP).
In addition to importing medicine and medical devices, Avin Darou Pharmaceutical Group operates in local manufacturing of various medicines, supplying drug delivery devices to pharmaceutical companies (B2B business), local manufacturing of supplements, and local distribution of medicine.
- Trust and integrity
- Respect and fairness
- Growth mindset and innovation
- Agility and Flexibility
- Passionate team
- Employee engagement
- Advancement opportunities
We strive to offer products of the best quality and in accordance with national and international standards in our organization through innovation and creativity. Furthermore, we fulfill our great responsibility towards community health by benefiting from the world’s cutting-edge technology, agile staff, and with respect to the environment, and reach impressive achievements in the pharmaceutical industry by developing our activities.